Top-News
Pharmazeutika Kanada

Medicure News

Aktie
WKN:  A1J7TZ ISIN:  CA58469E4085 US-Symbol:  MCUJF
0,74 €
+0,00 €
0,00%
15:13:13 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website

Medicure News

26.11.19 - PR Newswire
Medicure Reports Financial Results for Quarter Ended September 30, 2019
Medicure Reports Financial Results for Quarter Ended September 30, 2019 PR Newswire
19.11.19 - PR Newswire
Medicure Q3 2019 Results and Conference Call Dates
Medicure Q3 2019 Results and Conference Call Dates PR Newswire
13.11.19 - PR Newswire
Medicure Announces Commencement of Substantial Issuer Bid
Medicure Announces Commencement of Substantial Issuer Bid PR Newswire
04.11.19 - PR Newswire
Medicure Announces Intention to Commence Substantial Issuer Bid
Medicure Announces Intention to Commence Substantial Issuer Bid PR Newswire
15.10.19 - PR Newswire
Medicure Announces SMILE™-HF Study Demonstrates Use of ReDS™ Results in 58% Reduction in Hospital Readmission Rate
Medicure Announces SMILE™-HF Study Demonstrates Use of ReDS™ Results in 58% Reduction in Hospital Readmission Rate PR Newswire
03.10.19 - PR Newswire
Medicure Announces Preferred Pricing Agreement for Zypitamag™ with the AIDS Drug Assistance Program ("ADAP") Crisis Task Force
Medicure Announces Preferred Pricing Agreement for Zypitamag™ with the AIDS Drug Assistance Program ("ADAP") Crisis Task Force PR Newswire
30.09.19 - PR Newswire
Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag™
Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag™ PR Newswire
17.09.19 - PR Newswire
Medicure Announces Launch of New and Improved ReDS™ PRO
Medicure Announces Launch of New and Improved ReDS™ PRO PR Newswire
08.08.19 - PR Newswire
Medicure Reports Financial Results for Quarter Ended June 30, 2019
Medicure Reports Financial Results for Quarter Ended June 30, 2019 PR Newswire
02.08.19 - PR Newswire
Medicure Q2 2019 Results and Conference Call Dates
Medicure Q2 2019 Results and Conference Call Dates PR Newswire
26.06.19 - PR Newswire
Medicure Announces Results of 2019 Annual Meeting of Shareholders
Medicure Announces Results of 2019 Annual Meeting of Shareholders PR Newswire
10.06.19 - PR Newswire
Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer
Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer PR Newswire
30.05.19 - PR Newswire
Medicure Announces Renewal of its Normal Course Issuer Bid
Medicure Announces Renewal of its Normal Course Issuer Bid PR Newswire
27.05.19 - PR Newswire
Medicure Reports Financial Results for Quarter Ended March 31, 2019
Medicure Reports Financial Results for Quarter Ended March 31, 2019 PR Newswire
22.05.19 - PR Newswire
Medicure Q1 2019 Results and Conference Call Dates
Medicure Q1 2019 Results and Conference Call Dates PR Newswire
15.05.19 - PR Newswire
Medicure Appoints Ms. Manon Harvey to its Board of Directors
Medicure Appoints Ms. Manon Harvey to its Board of Directors PR Newswire
29.04.19 - PR Newswire
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018 PR Newswire
24.04.19 - PR Newswire
Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019
Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019 PR Newswire
13.02.19 - PR Newswire
Medicure Provides Update on Release of Holdback Funds from Apicore Sale
Medicure Provides Update on Release of Holdback Funds from Apicore Sale PR Newswire
28.01.19 - PR Newswire
Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States
Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States PR Newswire

Newssuche

Videos

newspaper
17.05.24 -5,31%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »